A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis

RecruitingNot a drug-phase studyMS (type not specified)NCT07033975

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Flavonoid-enriched Mediterranean Diet

What it measured

Main measures

  • Microbiota changes

    Three timepoints, before start of the strict diet (day 14), after the strict diet (day 31), and after the follow-up period of three months (day 122).

Who could take part

MS (type not specified) · 30 to 65 · EDSS 0 to 6

Show the full criteria

Inclusion criteria

* Expanded Disability Status Scale (EDSS): 0-6

Exclusion criteria

* Diagnosed digestive pathology

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.

Loading reviews and guidelines…

History

    1. Started

      Apr 2023

    2. Main results due

      Dec 2028

    3. Finished

      Dec 2028

    Assembled by software from public sources.